Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons drs. M.H. (Stanley) Yeung

Publicaties

Potassium intake, fibroblast growth factor 23 and clinical outcomes

Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in CKD

Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study

Low Urinary Potassium Excretion Is Associated with Higher Risk of All-Cause Mortality in Patients with Type 2 Diabetes: Results of the Dutch Diabetes and Lifestyle Cohort Twente (DIALECT)

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity

Net Endogenous Acid Excretion and Kidney Allograft Outcomes

Phosphate and fibroblast growth factor 23 in diabetes

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort

Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study

Lees meer